These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4984765)
21. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China. Liu H; Wang Y; Liu N; Zhao L Indian J Med Microbiol; 2015 Feb; 33 Suppl():164-5. PubMed ID: 25657144 [No Abstract] [Full Text] [Related]
22. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro. Suling WJ; Maddry JA J Antimicrob Chemother; 2001 Apr; 47(4):451-4. PubMed ID: 11266419 [TBL] [Abstract][Full Text] [Related]
23. In-vitro activity of N,N-dimethyl-2-propen-1-amines against Mycobacterium tuberculosis. De Souza AO; Aily DC; Sato DN; Durán N J Antimicrob Chemother; 1998 Sep; 42(3):407-8. PubMed ID: 9786490 [No Abstract] [Full Text] [Related]
24. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria. Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472 [No Abstract] [Full Text] [Related]
25. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Yan X; Lv Z; Wen J; Zhao S; Xu Z Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930 [TBL] [Abstract][Full Text] [Related]
26. Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis. Jeankumar VU; Chandran M; Samala G; Alvala M; Koushik PV; Yogeeswari P; Salina EG; Sriram D Bioorg Med Chem Lett; 2012 Dec; 22(24):7414-7. PubMed ID: 23137434 [TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid. Cicek-Saydam C; Cavusoglu C; Burhanoglu D; Hilmioglu S; Ozkalay N; Bilgic A Clin Microbiol Infect; 2001 Dec; 7(12):700-2. PubMed ID: 11843915 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives. Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613 [TBL] [Abstract][Full Text] [Related]
29. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
30. In vitro activity of antimicrobial agents against mycobacteria. Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951 [TBL] [Abstract][Full Text] [Related]
31. 2-N-Arylthiazole inhibitors of Mycobacterium tuberculosis. Clark MP; Wang T; Perola E; Deininger DD; Zuccola HJ; Jones SM; Gao H; VanderVen BC; Russell DG; Shoen CM; Cynamon MH; Thomson JA; Locher CP Bioorg Med Chem Lett; 2017 Sep; 27(17):3987-3991. PubMed ID: 28778468 [TBL] [Abstract][Full Text] [Related]
32. In-vitro activity of quinolones and macrolides against mycobacteria. Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Rodríguez JC; Ruiz M; López M; Royo G Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143 [TBL] [Abstract][Full Text] [Related]
34. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. Dinçer I; Ergin A; Kocagöz T Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094 [TBL] [Abstract][Full Text] [Related]
35. Effect of meropenem against multidrug-resistant Mycobacterium tuberculosis. Coban AY; Bilgin K; Tasdelen Fisgin N; Uzun M; Durupinar B J Chemother; 2008 Jun; 20(3):395-6. PubMed ID: 18606602 [No Abstract] [Full Text] [Related]
36. [Sensitivity and resistance of Mycobacterium tuberculosis var. hominis to isoniazid; studies on 322 strains isolated in tuberculous patients and action in vitro of antibiotic associations]. VIALLIER J; SERRE H; CAYRE RM Ann Inst Pasteur (Paris); 1953 Apr; 84(4):804-8. PubMed ID: 13124986 [No Abstract] [Full Text] [Related]
37. The effect of thiocarbanidin and related compounds on Mycobacterium tuberculosis var. hominis in vitro and in vivo. YOUMANS GP; YOUMANS AS; DOUB L Am Rev Tuberc; 1958 Feb; 77(2):301-10. PubMed ID: 13509028 [No Abstract] [Full Text] [Related]
38. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis. Vera-Cabrera L; Gonzalez E; Rendon A; Ocampo-Candiani J; Welsh O; Velazquez-Moreno VM; Choi SH; Molina-Torres C Antimicrob Agents Chemother; 2006 Sep; 50(9):3170-2. PubMed ID: 16940121 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids. Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of coumermycin A1. Fedorko J; Katz S; Allnoch H Appl Microbiol; 1969 Nov; 18(5):869-73. PubMed ID: 4391844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]